If you've been treating federal quantum policy as background noise, this week turned the volume up. The U.S. government is no longer just funding research; it's writing the kind of checks that crown winners and, in at least one reported case, taking equity in them.
Two distinct federal commitments stacked on the same Thursday. A $1B Letter of Intent from the Department of Commerce to fund an IBM quantum foundry under the CHIPS Act. And a separate $2.013B program of nine more LOIs, officially announced by Commerce later in the day, with recipients including PsiQuantum ($100M), D-Wave (QBTS, $100M), Diraq ($38M, silicon-spin), and Quantinuum (the Honeywell trapped-ion subsidiary). Together, they reframe the question every pure-play investor has been asking: when does federal money start picking the winners?
Two things from this week worth your attention, plus one pattern worth flagging.
The Department of Commerce signed a $1B CHIPS Act LOI with IBM for a purpose-built quantum foundry.
This is the largest single federal commitment to a named public quantum vendor in the sector's short history. The Letter of Intent (LOI) funds dedicated quantum chip fabrication infrastructure: the kind of supply-chain asset every superconducting program in the field currently has to beg, borrow, or share access to.
My read is that this matters less for IBM's stock (quantum is rounding error against IBM's market cap) and more for what it tells you about how Washington is now thinking about quantum hardware. Dedicated foundry capacity is the kind of bet a government places when it has decided a technology category will matter at scale, and that domestic production of it is a strategic interest. The semiconductor analogy is on the nose; that's the policy template being applied.
For the superconducting pure-plays — Rigetti most directly — the read is mixed. Sector validation is real; an IBM foundry could eventually lower fabrication costs across the architecture. But a billion-dollar federal-backed manufacturing moat is also something Rigetti doesn't have and now has to compete against. For IonQ, the read is cleaner: the announcement makes the SkyWater vertical-integration bet look like the right strategic instinct for a pure-play that needs fab independence. Trapped-ion doesn't compete for the same fab capacity, and IBM just showed what government-backed quantum manufacturing looks like at scale.
The caveat: an LOI is not a final award. CHIPS Act LOIs have converted at high rates historically, but the conversion isn't free. A final award would confirm the existing read, not generate a fresh catalyst.
The U.S. signed nine LOIs for $2.013B in CHIPS Act funding, with D-Wave (QBTS) the named public-ticker recipient.
Reuters and others reported the program in the morning; the Department of Commerce confirmed it officially Thursday afternoon. Named recipients so far: PsiQuantum ($100M), D-Wave ($100M), Diraq ($38M, silicon-spin), and Quantinuum. Five more haven't been publicly named yet. D-Wave is the only currently-public US ticker on the named list — the public-market name-level catalyst the morning report left hypothetical.
The structure of the funding is the more interesting question. Equity stakes are not how the U.S. government has historically funded quantum. Grants, yes. Procurement contracts, yes. DARPA milestone payments, yes. Equity participation alongside private capital is a different posture — it says Washington is treating quantum hardware as a strategic investment, not a research subsidy. The semiconductor CHIPS playbook had some equity-adjacent structures (Intel, TSMC, Samsung); applying that template to a sector where most of the candidate vendors are sub-$5B public pure-plays or pre-IPO privates is a meaningful escalation.
The read tightens immediately on QBTS. A $100M LOI to a sub-$5B-cap pure-play is roughly 10% of market cap; that's the kind of award size that argues for adding rather than waiting. The privates on the list (Quantinuum, PsiQuantum, Diraq) reinforce the wave of quantum IPOs building behind the listings already complete. Government co-investors lower the perceived risk for the public-market capital that follows, and Quantinuum specifically accelerates the Honeywell IPO arithmetic. The remaining five unnamed recipients are the next thing worth watching; additional named publics in that list would each be standalone name-level catalysts.
The reaction window hasn't opened on either announcement as I write this. The tape will tell us how the market is sorting validation-without-names from the IBM-specific commitment.
Other items worth flagging.
The pattern these two announcements form together. Look at the same Thursday from a slightly different altitude: one named-vendor, named-dollar, named-asset commitment ($1B, IBM, foundry), and one named-dollar, named-vehicle-count, unnamed-vendor commitment ($2B, nine companies, equity stakes). That's not two news items; that's an industrial policy taking shape. The U.S. is signaling, on both infrastructure and on operating companies, that quantum hardware is now a category it intends to fund as it would a strategic semiconductor sector. The interesting question is whether the next CHIPS LOI lands on a pure-play rather than a hyperscaler. That's the announcement that would move the names directly.
What to watch next week.
The naming of the nine recipients in the $2B program is the catalyst. Reuters and WSJ are usually within a week of the initial report on follow-up naming; expect specifics in the next ten days. Each named public ticker is a potential name-level catalyst in its own right. Watch also for any sympathy reaction in the superconducting pure-plays (RGTI most directly, IQM once it lists) to the IBM foundry LOI. If the tape reads it as a moat rather than as validation, that's a different setup than my current read assumes.
For now: the volume on federal quantum policy went up this week, and the policy itself looks more concrete than it did seven days ago. The companies named in the next round of headlines will move on their own; the companies not named will need a different reason to move.
Not investment advice. For informational purposes only.
Position disclosure: The author may hold positions in companies referenced.